Parkinson

A case of probable Parkinson’s disease after SARS-CoV-2 infection

The Lancet Neurology Fecha de publicación: October 2020 DOI: https://doi.org/10.1016/S1474-4422(20)30305-7 Autores: Mikhal E Cohen, Roni Eichel, Bettina Steiner-Birmanns, Amir Janah, Maxim Ioshpa, Rachel...

Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism

Journal of Neurology, Neurosurgery & Psychiatry Fecha de publicación: 18 June 2020 DOI: http://dx.doi.org/10.1136/jnnp-2019-322588 Autores: Cheng Jiang, Franziska Hopfner, Antigoni...

Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson’s disease: a randomised, single-blinded, phase 1 trial

The Lancet Neurology Fecha de publicación: July 2020 DOI: https://doi.org/10.1016/S1474-4422(20)30136-8 Autores: Dieter Volc, MD., Prof Werner Poewe, MD., Alexandra Kutzelnigg,...

La reprogramación de células abre la puerta al tratamiento del párkinson

Un equipo de investigadores del Hospital McLean y el Hospital General de Massachusetts (MGH), en Estados Unidos, ha demostrado que...

Tobacco smoking and the reduced risk of Parkinson disease

Neurology Journal Fecha de publicación: 5 May 2020 DOI: https://doi.org/10.1212/WNL.0000000000009431 Autores: Yuan Cheng, Yan-Jiang Wang Background: Parkinson disease (PD) is...